Familial lecithin-cholesterol acyltransferase deficiency (Q97092): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
A deficiência familiar de lecitina-colesterol aciltransferase é uma forma de deficiência de lecitina-colesterol aciltransferase caracterizada clinicamente por opacidades da córnea, anemia hemolítica e insuficiência renal, e bioquimicamente por colesterol HDL severamente diminuído e deficiência completa de LCAT enzima. | |||
| description / en | description / en | ||
Familial LCAT (lecithin-cholesterol acyltransferase) deficiency (FLD) is a form of lecithin-cholesterol acyltransferase deficiency (LCAT) characterised clinically by corneal opacities, haemolytic anaemia, and renal failure, and biochemically by severely decreased HDL cholesterol and complete deficiency of the LCAT enzyme. | |||
Revision as of 13:07, 16 August 2026
Familial LCAT (lecithin-cholesterol acyltransferase) deficiency (FLD) is a form of lecithin-cholesterol acyltransferase deficiency (LCAT) characterised clinically by corneal opacities, haemolytic anaemia, and renal failure, and biochemically by severely decreased HDL cholesterol and complete deficiency of the LCAT enzyme.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1147277534 |
||
| English | Familial lecithin-cholesterol acyltransferase deficiency |
Familial LCAT (lecithin-cholesterol acyltransferase) deficiency (FLD) is a form of lecithin-cholesterol acyltransferase deficiency (LCAT) characterised clinically by corneal opacities, haemolytic anaemia, and renal failure, and biochemically by severely decreased HDL cholesterol and complete deficiency of the LCAT enzyme. |
